Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY - Warrant Activity (Details)

v3.21.1
STOCKHOLDERS' EQUITY - Warrant Activity (Details)
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Number of Warrants  
Outstanding, beginning of the period (in shares) | shares 6,167,745
Issued (in shares) | shares 773,000
Exercised (in shares) | shares (2,169,021)
Expired (in shares) | shares 0
Outstanding, end of the period (in shares) | shares 4,771,724
Exercisable (in shares) | shares 4,595,254
Weighted Average Exercise Price  
Outstanding, beginning of the period (in dollars per share) | $ / shares $ 5.26
Issued (in dollars per share) | $ / shares 5.50
Exercised (in dollars per share) | $ / shares 5.07
Expired (in dollars per share) | $ / shares 0.00
Outstanding, end of the period (in dollars per share) | $ / shares 5.39
Exercisable (in dollars per share) | $ / shares $ 5.35
Weighted Average Remaining Life, Outstanding (in years) 4 years 3 months 18 days
Weighted Average Remaining Life, Exercisable (in years) 4 years 2 months 12 days
Intrinsic Value, Outstanding (in dollars) | $ $ 9,108,803
Intrinsic Value, Exercisable (in dollars) | $ $ 8,946,451
Warrants to purchase shares of common stock | shares 462,997
Exercise price of warrants (in dollars per share) | $ / shares $ 5.50